A systematic approach for early identification of BP effects during development of new drugs.
Daniel B. Goodman, MD
Advertisement
Articles by Daniel B. Goodman, MD
More attention is being paid to blood pressure effects in new chemical entities under development for non-hypertension indications.
Advertisement
Latest Updated Articles
A Proposed Approach for Blood Pressure Evaluation During Early Phase Human Trials of New DrugsPublished: July 22nd 2014 | Updated:
- Blood Pressure Evaluation During Early Phase Trials
Published: October 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
2
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
3
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
4
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
